This study is currently recruiting.
Description: This research study is being conducted to evaluate how the study drug, methylphenidate, affects brain activity and brain chemistry in righthanded children ages 6-17 years with ADHD. The study consists of three onsite visits and involves neuropsychological testing along with functional MRI and magnetic resonance spectroscopy (MRS) scans after a single dose of each treatment (i.e., placebo, low dose of methylphenidate, and higher dose). Eligible participants may earn up to $300 for completing the study.
Eligibility & Criteria
IRB #: IRB00276357
Principal Investigator: Bradley Grant, DO
Eligible Age Range: 6 to 17 years
Gender: All
Diagnosis: ADHD